Remove 2021 Remove Compounding Remove Pharmaceutical Companies
article thumbnail

Preventing fungal contamination in pharmaceuticals

European Pharmaceutical Review

In a review on fungal-contaminated compounded pharmaceuticals and medical devices, researchers have described how the contamination of these products can be due to breaches in sterile compounding procedures. One case of drug contamination from 2021 was highlighted in the paper. Ahmed et al. Ahmed et al.

article thumbnail

OSD contract manufacturing market valued at $54.7 billion by 2030

European Pharmaceutical Review

billion by 2030, displaying a compound annual growth rate (CAGR) of 6.0 Tablets were noted to be the most common form of OSD in 2021 because of their convenience and simplicity in production, transportation and delivery to the end user. This is especially beneficial as a way of decreasing potential side effects.

Dosage 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Utilising content metrics to improve digital engagement

pharmaphorum

The 2021 Veeva Pulse Content Metrics Report provides information on how current digital trends impact the commercial content landscape and how Veeva utilises these trends to improve brand engagement. Digital content can then be approved quicker without jeopardising content compliant delivery.

article thumbnail

The osteoarthritis market is expected to increase to $3.8bn in 2031

Pharmaceutical Technology

billion in the 7MM (seven major markets) in 2021, and is expected to increase to $3.8 billion in 2031, at a compound annual growth rate (CAGR) of 4.4%. The OA space has long been dominated by large pharmaceutical companies such as Bayer, Pfizer, and Eli Lilly. The osteoarthritis (OA) market was valued at $2.5

article thumbnail

STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes

STAT

Pharmaceutical companies could be made to disclose prices and deals for products they make to fight future global health emergencies, under new rules that would govern a World Health Organization-backed pandemic accord , Reuters reports. Or you may want to take stock of your life. Well, whatever you do, have a grand time.

FDA 85
article thumbnail

AstraZeneca extends oncology partnership with Proteros

pharmaphorum

Its work focuses on the discovery and development of novel epigenetic drugs, which it does for the majority of the world’s leading pharmaceutical companies. Proteros’s expertise and tools speed up the research process, particularly at the initial drug discovery and development stages.

article thumbnail

Innovation in chemotherapy: Leading companies in platinum-based cancer drug compositions

Pharmaceutical Technology

These compounds cause their therapeutic effect by inhibiting DNA synthesis. GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.